CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study
(Q81205526)
scientific article published on 01 November 2004
scientific article published on 01 November 2004
Language:
Current Data About
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study
other details
description | scientific article published on 01 November 2004 |
External Links
(P356) |
10.1007/S10875-004-6244-3
|
(P698) |
15622454
|
(P6179) |
1024011284
|